Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
For long-term weight loss, its crucial to learn how to eat and change eating habits
Anesthesia considerations for a patient on semaglutide and delayed gastric emptying
PLOS ONE 8 , e69010 (2013)
However, the company faces intensifying competition from Eli Lilly's tirzepatide (Mounjaro, Zepbound), which has demonstrated superior weight loss efficacy, reshaping prescriber preferences in obesity management [2]
US$ 28.97
US$ 29.45
US$ 27.46
